A potentially breathable, respiratory vaccine in development has been shown to provide long-term protection for non-human primates against the deadly Ebola virus, as reported this week in the online edition of the...
Tests reveal certain strains survive for weeks when stored at low temperatures. The number of confirmed Ebola cases passed the 10,000 mark, despite efforts to curb its spread. And while the disease typically dies on...
The DNA of a virus once thought confined to the cells of algae may in fact invade the biological kingdom of mice and men, according to a new study from researchers at Johns Hopkins and UNL. The researchers, whose paper...
In the absence of credible, strong political leadership, paranoia about disease can go viral. We’ve seen this happen around the world with a wide range of illnesses, from swine flu to SARS to Ebola. And even after...
No vaccines or drugs are available yet to protect people worldwide against Ebola virus disease, but two potential vaccines are in human safety testing, and scientists at the U.S. Army Medical Research Institute of...
Rapid detection of viruses among potential applications of research at UC Santa Cruz. In 2010, Ahmet Ali Yanik published his first paper on the rapid detection of Ebola virus using new biosensor technology, he and...
Epidemics like the current Ebola outbreak in West Africa often get started when people make contact with animals carrying infectious diseases, but, paradoxically, a certain amount of human exposure to a virus at its...
Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health’s Clinical Center in Bethesda, Maryland. Researchers at the National Institute of Allergy and...
A new HIV/AIDS vaccine, developed by Chinese scientists, has completed its safety testing stage, the results of which will soon be submitted to the Chinese authorities, experts said during the 2014 National Conference...
Russian scientists are developing a technology to make monoclonal antibodies specific to the Ebola virus. If successful, the resulting medicine could be available as soon as December. Testing points to a positive effect...